Printer Friendly

CEPHALON NAMES BRUCE PEACOCK EXECUTIVE VICE PRESIDENT-CFO

 CEPHALON NAMES BRUCE PEACOCK EXECUTIVE VICE PRESIDENT-CFO
 WEST CHESTER, Pa., Feb. 3 /PRNewswire/ -- Cephalon (NASDAQ: CEPH) announced today that Bruce A. Peacock has joined the company as executive vice president-chief financial officer. The announcement was made today by Frank Baldino Jr. Ph.D., president and CEO of Cephalon, Inc.
 For the 10 years prior to joining Cephalon, Peacock held increasingly important financial positions with Centocor, Inc. where he last served as senior vice president and chief financial officer. During his tenure with Centocor, Peacock was responsible for raising over $750 million through common stock, limited partnership, SWORD and convertible debt offerings in both the United States and abroad. He recently completed the $100 million Tocor II offering.
 "Bruce will be a tremendous addition to the Cephalon management team," indicated Baldino. "His leadership and experience at Centocor, a first tier biotechnology company, will significantly impact Cephalon's operations as we move our technology closer to commercialization."
 Cephalon was founded in 1987 to discover, develop and commercialize novel therapeutic products for the treatment of stroke and neurodegenerative disorders including ALS and Alzheimer's disease.
 -0- 2/3/92
 /CONTACT: Nicole Vitullo of Cephalon, 215-344-0200/
 (CEPH) CO: Cephalon, Inc. ST: Pennsylvania IN: MTC SU: PER


PS-OS -- NY003 -- 5966 02/03/92 08:00 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 3, 1992
Words:209
Previous Article:STATE EMPLOYEES RATIFY CONTRACT BY WIDE MARGIN RECORD TURNOUT SIGNALS SUPPORT FOR NEW TWO-YEAR PACT
Next Article:COUNTRYWIDE'S JANUARY MORTGAGE ORIGINATIONS UP 288 PERCENT; REACH RECORD $1.6 BILLION
Topics:


Related Articles
CEPHALON NAMES VICE PRESIDENT OF DRUG DEVELOPMENT
CEPHALON NAMES DIRECTOR OF BUSINESS DEVELOPMENT
CEPHALON APPOINTS DIRECTOR OF MEDICAL AFFAIRS
CEPHALON NAMES KEVIN BUCHI VICE PRESIDENT FINANCE AND ADMINISTRATION
CEPHALON APPOINTS JOSEPH DAY SENIOR VICE PRESIDENT, WORLDWIDE CORPORATE DEVELOPMENT
CEPHALON APPOINTS MONROE KLEIN VICE PRESIDENT, WORLDWIDE REGULATORY AFFAIRS
CEPHALON EXPANDS DRUG DEVELOPMENT GROUP
CEPHALON APPOINTS ROBERT ROCHE VICE PRESIDENT, SALES AND MARKETING
GUILFORD PHARMACEUTICALS APPOINTS TWO KEY EXECUTIVES

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters